The present invention provides novel compounds which activate the Kv7 potassium channels. Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat disorders responsive to the activation of Kv7 potassium channels.La présente invention concerne de nouveaux composés qui activent les canaux potassiques Kv7. Des aspects séparés de l'invention concernent des compositions pharmaceutiques comprenant lesdits composés et des utilisations des composés pour traiter des troubles sensibles à l'activation de canaux potassiques Kv7.